Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DAO | P14920 | 6/20 | 0.50 |
| ▸ | PKM | P14618 | 1/20 | 0.45 |
| ▸ | LIG1 | P18858 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | RARB | P10826 | 2/20 | 0.40 |
| ▸ | RARG | P13631 | 2/20 | 0.40 |
| ▸ | RXRA | P19793 | 2/20 | 0.40 |
| ▸ | RXRB | P28702 | 2/20 | 0.40 |
| ▸ | RXRG | P48443 | 2/20 | 0.40 |
| ▸ | RARA | P10276 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.39 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.39 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29957199 | 0.88 | MEN1 (0.50) | DAOMEN1POLBRAB9AKMT2A | |
| SCHEMBL6559263 | 0.87 | NPSR1 (0.49) | DAOPKMLIG1POLBRARB | |
| SCHEMBL3495814 | 0.86 | DAO (0.43) | DAOPKMLIG1RAB9ARARB | |
| SCHEMBL22380001 | 0.84 | DAO (0.52) | DAOPKMLIG1MEN1POLB | |
| SCHEMBL8429397 | 0.80 | F2 (0.54) | DAOMEN1KMT2AALDH1A1ERN1 | |
| SCHEMBL21234794 | 0.80 | ALDH1A1 (0.36) | DAOALDH1A1HPGD | |
| SCHEMBL9074074 | 0.80 | DAO (0.48) | DAOPKMLIG1MEN1POLB | |
| SCHEMBL6211353 | 0.80 | LMNA (0.48) | DAORAB9AKDM4EALDH1A1GAA | |
| SCHEMBL2226671 | 0.79 | NPSR1 (0.53) | DAOPKMPOLBRAB9AKMT2A | |
| SCHEMBL7823523 | 0.79 | LMNA (0.40) | DAOPKMLIG1ERN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 479 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250327191-A1 | CORROSSION INHIBITOR COMPOSITIONS | TATA CONSULTANCY SERVICES LIMITED (IN) | 2025-10-23 | — | — | US | claimed |
| EP-4636130-A1 | CORROSSION INHIBITOR COMPOSITIONS | Tata Consultancy Services Limited (IN) | 2025-10-22 | — | — | EP | claimed |
| CN-116200027-B | Flame-retardant nylon and preparation method thereof | 浙大宁波理工学院 | 2024-11-01 | — | — | CN | claimed |
| CN-111978740-B | Solid-phase renewable silicone rubber and preparation method and application thereof | 广东工业大学 | 2022-05-20 | — | — | CN | claimed |
| CN-113462381-A | Polar sensitive NIR probe with high binding force with amyloid fiber and preparation and application thereof | 首都师范大学 | 2021-10-01 | — | — | CN | claimed |
| CN-111978740-A | Solid-phase renewable silicone rubber and preparation method and application thereof | 广东工业大学 | 2020-11-24 | — | — | CN | claimed |
| US-20110306775-A1 | SYNTHESIS AND BIOLOGICAL EVALUATION OF 2',5'-DIMETHOXYCHALCONE DERIVATIVES AS MICROTUBULE-TARGETED ANTICANCER AGENTS | KAOHSIUNG MEDICAL UNIVERSITY (TW) | 2011-12-15 | — | — | US | claimed |
| EP-4743175-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS | Aconcagua Bio, Inc. (US) | 2026-05-20 | — | — | EP | disclosed |
| EP-4743174-A1 | MODULATORS OF CALCITONIN RECEPTOR AND/OR AMYLIN RECEPTOR ACTIVITY | Aconcagua Bio, Inc. (US) | 2026-05-20 | — | — | EP | disclosed |
| US-20260069602-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS | ACONCAGUA BIO INC (US) | 2026-03-12 | — | — | US | disclosed |
| US-12503468-B2 | Heterocyclic compound, intermediate, preparation method therefor and application thereof | WUHAN LL SCIENCE AND TECHNOLOGY DEVELOPMENT CO., LTD. (CN) | 2025-12-23 | — | — | US | disclosed |
| US-12479834-B2 | Phenol compound or salt thereof | TAIHO PHARMACEUTICAL CO., LTD. (JP) | 2025-11-25 | — | — | US | disclosed |
| US-20250327191-A1 | CORROSSION INHIBITOR COMPOSITIONS | TATA CONSULTANCY SERVICES LIMITED (IN) | 2025-10-23 | — | — | US | disclosed |
| US-5047554-A | 3-substituted-2-oxindole derivatives | PFIZER INC. (US) | 1991-09-10 | — | — | US | disclosed |
| EP-0434426-A1 | Condensed heterocyclic compounds, their production and use | Takeda Chemical Industries, Ltd. (JP) | 1991-06-26 | — | — | EP | disclosed |
| EP-0418924-A2 | Pyrrolopyrimidines, their production and use | Takeda Chemical Industries, Ltd. (JP) | 1991-03-27 | — | — | EP | disclosed |
| US-4996227-A | Administering nontoxic antitumor agents | UNIVERSITY OF CINCINNATI (US) | 1991-02-26 | — | — | US | disclosed |
| EP-0393936-A1 | 3-substituted-2-oxindole derivatives as antiinflammatory agents | PFIZER INC. (US) | 1990-10-24 | — | — | EP | disclosed |
| US-4518609-A | ANTITUMOR, SKIN DISORDERS | SRI INTERNATIONAL (US) | 1985-05-21 | — | — | US | disclosed |
| US-4456618-A | ANTITUMOR AGENTS, TREATMENT OF SKIN DISORDERS | SRI INTERNATIONAL (US) | 1984-06-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12503468-B2 | Heterocyclic compound, intermediate, preparation method therefor and application thereof | P2RX3, P2RX7, P2RX4 | DAO 3298/4885PKM 2394/4885LIG1 3854/4885 |
| US-12479834-B2 | Phenol compound or salt thereof | REN, MLX, MYB | DAO 2265/4885PKM 3542/4885LIG1 2510/4885 |
| US-20110306775-A1 | SYNTHESIS AND BIOLOGICAL EVALUATION OF 2',5'-DIMETHOXYCHALCONE DERIVATIVES AS MICROTUBULE-TARGETED ANTICANCER AGENTS | TUBB1, TUBB6, TUBA1C | DAO 2205/4885PKM 2007/4885LIG1 1153/4885 |
| US-20260069602-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS | SCTR, SSTR1, NPY1R | DAO 2925/4885PKM 4694/4885LIG1 3127/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.